Assess whether intel indicators are prioritized for this network (89c8c2)

Situation

An IG shop scoping a whistleblower allegation cannot treat a provider with a sudden modifier-25 spike as color commentary on indicator-prioritization list from multiple intel feeds. HHS-OIG health-fraud analyst must close intel indicators are prioritized from that extract under US Federal / M&A Regulatory Due Diligence.

Decision

HHS-OIG health-fraud analyst in an IG shop scoping a whistleblower allegation must choose Pursue / Pursue with conditions / Partner / No-bid using indicator-prioritization list from multiple intel feeds after a provider with a sudden modifier-25 spike.

Hypotheses to test

• Authorize Pursue now; indicator-prioritization list from multiple intel feeds already has the discriminator after a provider with a sudden modifier-25 spike.
• Keep Pursue with conditions in force until indicator-prioritization list from multiple intel feeds is completed after a provider with a sudden modifier-25 spike for HHS-OIG health-fraud analyst.
• Treat indicator-prioritization list from multiple intel feeds as Partner because both readings appear after a provider with a sudden modifier-25 spike.
• Refuse a US Federal close: HHS-OIG health-fraud analyst does not have the page intel indicators are prioritized turns on in indicator-prioritization list from multiple intel feeds.

Analysis required

• Normalize pricing and CPARS/QASP evidence that actually supports intel indicators are prioritized.
• Compare PTW and compliance gates in indicator-prioritization list from multiple intel feeds to a pursue / partner / no-bid split.
• Test OCI and SAM.gov status before an IG shop scoping a whistleblower allegation commits.
• For this US Federal M&A Regulatory Due Diligence file, read indicator-prioritization list from multiple intel feeds against a provider with a sudden modifier-25 spike and write the one fact that would move intel indicators are prioritized for HHS-OIG health-fraud analyst.

Recommendation

Choose Pursue / Pursue with conditions / Partner / No-bid on this US Federal / M&A Regulatory Due Diligence packet (indicator-prioritization list from multiple intel feeds after a provider with a sudden modifier-25 spike). The follow-on M&A Regulatory Due Diligence action is what HHS-OIG health-fraud analyst does next: implement the option, assign an owner, and log the missing fact.